PDB74 - IDEGLIRA VERSUS IGLARLIXI FOR PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES ON BASAL INSULIN- A LONG-TERM COST-EFFECTIVENESS ANALYSIS IN THE CZECH REPUBLIC
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.779
https://www.valueinhealthjournal.com/article/S1098-3015(18)34079-8/fulltext
Title :
PDB74 - IDEGLIRA VERSUS IGLARLIXI FOR PATIENTS WITH INADEQUATELY CONTROLLED TYPE 2 DIABETES ON BASAL INSULIN- A LONG-TERM COST-EFFECTIVENESS ANALYSIS IN THE CZECH REPUBLIC
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)34079-8&doi=10.1016/j.jval.2018.09.779
First page :
Section Title :
Open access? :
No
Section Order :
178